CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $31,000 | -99.8% | 12,434 | -99.8% | 0.00% | -100.0% |
Q1 2017 | $19,020,000 | -13.8% | 5,268,540 | -15.5% | 0.01% | -9.1% |
Q4 2016 | $22,065,000 | -13.4% | 6,233,265 | -1.1% | 0.01% | -15.4% |
Q3 2016 | $25,465,000 | -8.0% | 6,303,200 | -0.1% | 0.01% | -13.3% |
Q2 2016 | $27,692,000 | -19.2% | 6,307,998 | -30.4% | 0.02% | -16.7% |
Q1 2016 | $34,271,000 | -77.7% | 9,066,397 | -7.5% | 0.02% | -76.9% |
Q4 2015 | $153,743,000 | +60.7% | 9,804,892 | +8.0% | 0.08% | +66.0% |
Q3 2015 | $95,688,000 | -56.1% | 9,078,447 | +5.1% | 0.05% | -52.5% |
Q2 2015 | $217,878,000 | -9.9% | 8,639,085 | -0.4% | 0.10% | -10.0% |
Q1 2015 | $241,719,000 | +38.4% | 8,673,154 | -9.4% | 0.11% | +39.2% |
Q4 2014 | $174,655,000 | +31.8% | 9,570,072 | -6.4% | 0.08% | +31.7% |
Q3 2014 | $132,546,000 | -23.4% | 10,227,454 | -3.5% | 0.06% | -21.1% |
Q2 2014 | $173,018,000 | -0.9% | 10,601,693 | +7.3% | 0.08% | -7.3% |
Q1 2014 | $174,636,000 | -9.0% | 9,883,257 | +24.6% | 0.08% | -12.8% |
Q4 2013 | $191,985,000 | -32.2% | 7,930,026 | -0.8% | 0.09% | -37.7% |
Q3 2013 | $283,283,000 | +112.3% | 7,995,626 | -6.5% | 0.15% | +98.7% |
Q2 2013 | $133,451,000 | – | 8,549,034 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
LMR Partners LLP | 408,846 | $206,000 | 0.01% |